Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -6.55% is 218% below its 5-year average of -2.06%, near the low end of its 5-year range (-11.54%–6.09%).
24.05% below its 12-month average of -5.28%.
Reported quarterly return on assets; no daily interpolation. Q3 FY2026 (2026-06-30): 0.13%.
RETURN ON ASSETS (ROA)
-6.55%
RETURN ON ASSETS (ROA) AVG TTM
-5.28%
RETURN ON ASSETS (ROA) AVG 3Y
-5.65%
RETURN ON ASSETS (ROA) AVG 5Y
-2.06%
RETURN ON ASSETS (ROA) AVG 10Y
0.01%
RETURN ON ASSETS (ROA) AVG 15Y
3.15%
RETURN ON ASSETS (ROA) AVG 20Y
3.07%
CURRENT VS TTM AVG
-24.05%
CURRENT VS 3Y AVG
-15.98%
CURRENT VS 5Y AVG
-218.48%
CURRENT VS 10Y AVG
-65600.00%
CURRENT VS 15Y AVG
-308.10%
CURRENT VS 20Y AVG
-313.36%
SECTOR MEDIAN · HEALTHCARE
-30.18%
median of 674 covered companies
CURRENT VS SECTOR MEDIAN
+78.30%
vs the sector median at left
Azenta, Inc.
Market Cap
$1.87B
Return on Assets (ROA)
-6.55%
TTM Avg
-5.28%
3Y Avg
-5.65%
5Y Avg
-2.06%
Market Cap
$1.88B
Return on Assets (ROA)
-25.92%
TTM Avg
12.70%
3Y Avg
-8.51%
5Y Avg
-21.36%
Market Cap
$1.89B
Return on Assets (ROA)
11.27%
TTM Avg
-4.02%
3Y Avg
-13.89%
5Y Avg
-9.34%
Market Cap
$1.91B
Return on Assets (ROA)
-37.11%
TTM Avg
4.34%
3Y Avg
-11.90%
5Y Avg
4.27%
Market Cap
$1.84B
Return on Assets (ROA)
1.78%
TTM Avg
2.10%
3Y Avg
3.84%
5Y Avg
3.40%
Market Cap
$1.85B
Return on Assets (ROA)
-45.02%
TTM Avg
-50.76%
3Y Avg
-46.27%
5Y Avg
-37.50%
Market Cap
$1.83B
Return on Assets (ROA)
-18.68%
TTM Avg
-15.27%
3Y Avg
-14.09%
5Y Avg
-9.93%
Market Cap
$1.82B
Return on Assets (ROA)
10.25%
TTM Avg
8.68%
3Y Avg
8.17%
5Y Avg
8.38%
Market Cap
$1.95B
Return on Assets (ROA)
-11.05%
TTM Avg
-19.34%
3Y Avg
-25.88%
5Y Avg
-26.23%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Azenta, Inc. (AZTA) | $1.87B | -6.55% | -5.28% | -5.65% | -2.06% |
| Novavax, Inc. (NVAX)vs › | $1.88B | -25.92% | 12.70% | -8.51% | -21.36% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 11.27% | -4.02% | -13.89% | -9.34% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.91B | -37.11% | 4.34% | -11.90% | 4.27% |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 1.78% | 2.10% | 3.84% | 3.40% |
| Absci Corporation (ABSI)vs › | $1.85B | -45.02% | -50.76% | -46.27% | -37.50% |
| Novocure Ltd (NVCR)vs › | $1.83B | -18.68% | -15.27% | -14.09% | -9.93% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 10.25% | 8.68% | 8.17% | 8.38% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.95B | -11.05% | -19.34% | -25.88% | -26.23% |
| AxoGen, Inc. (AXGN)vs › | $1.96B | -11.00% | -5.98% | -9.46% | -10.43% |
ROA
-6.5%
ROE
-8.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-09-30 | -2.71% |
| 2024-09-30 | -7.85% |
| 2023-09-30 | -0.49% |
| 2022-09-30 | -11.54% |
| 2021-09-30 | 6.09% |
| 2020-09-30 | 4.16% |
| 2019-09-30 | 1.90% |
| 2018-09-30 | 10.64% |
| 2017-09-30 | 8.17% |
| 2016-09-30 | -10.13% |
| 2015-09-30 | 1.87% |
| 2014-09-30 | 0.57% |
| 2013-09-30 | -0.30% |
| 2012-09-30 | 18.44% |
| 2011-09-30 | 20.16% |
| 2010-09-30 | 11.38% |
| 2009-09-30 | -55.13% |
| 2008-09-30 | -35.66% |
| 2007-09-30 | 6.66% |
| 2006-09-30 | 2.61% |
| 2005-09-30 | -1.30% |
| 2004-09-30 | 4.05% |
| 2003-09-30 | -37.70% |
| 2002-09-30 | -109.50% |
| 2001-09-30 | -4.21% |
| 2000-09-30 | 2.49% |
| 1999-09-30 | -4.46% |
| 1998-09-30 | -13.05% |
| 1997-09-30 | 0.53% |
| 1996-09-30 | 13.12% |
